These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22430235)

  • 1. Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?
    Heenen S; Jacobs F; Vincent JL
    Crit Care Med; 2012 May; 40(5):1404-9. PubMed ID: 22430235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.
    Mokart D; Slehofer G; Lambert J; Sannini A; Chow-Chine L; Brun JP; Berger P; Duran S; Faucher M; Blache JL; Saillard C; Vey N; Leone M
    Intensive Care Med; 2014 Jan; 40(1):41-9. PubMed ID: 24231857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Empiric de-escalation strategy of antibiotic treatment].
    Adukauskiene D; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(9):703-8. PubMed ID: 17028467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Corcia-Palomo Y; Fernández-Delgado E; Herrera-Melero I; Ortiz-Leyba C; Márquez-Vácaro JA
    Intensive Care Med; 2014 Jan; 40(1):32-40. PubMed ID: 24026297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.
    Leone M; Bechis C; Baumstarck K; Lefrant JY; Albanèse J; Jaber S; Lepape A; Constantin JM; Papazian L; Bruder N; Allaouchiche B; Bézulier K; Antonini F; Textoris J; Martin C;
    Intensive Care Med; 2014 Oct; 40(10):1399-408. PubMed ID: 25091790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study.
    Moraes RB; Guillén JA; Zabaleta WJ; Borges FK
    Rev Bras Ter Intensiva; 2016 Sep; 28(3):315-322. PubMed ID: 27626951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
    Gomes Silva BN; Andriolo RB; Atallah AN; Salomão R
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007934. PubMed ID: 21154391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
    Silva BN; Andriolo RB; Atallah AN; Salomão R
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD007934. PubMed ID: 23543557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
    Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
    Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of antimicrobial therapy in intensive care units.
    Textoris J; Wiramus S; Martin C; Leone M
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):97-109. PubMed ID: 21171881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De-escalation therapy in ventilator-associated pneumonia.
    Rello J; Vidaur L; Sandiumenge A; Rodríguez A; Gualis B; Boque C; Diaz E
    Crit Care Med; 2004 Nov; 32(11):2183-90. PubMed ID: 15640629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationalising empirical antibiotics for bloodstream infections: A retrospective study at a South African district-level hospital.
    Engelbrecht A; Van der Westerhuizen C; Taljaard JJ
    S Afr Med J; 2022 Feb; 112(1):13520. PubMed ID: 35140001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program.
    Liu P; Ohl C; Johnson J; Williamson J; Beardsley J; Luther V
    BMC Infect Dis; 2016 Dec; 16(1):751. PubMed ID: 27955625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new paradigm for treating infections: "go hard and go home".
    Lipman J; Boots R
    Crit Care Resusc; 2009 Dec; 11(4):276-81. PubMed ID: 20001878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
    De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
    Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bloodstream infections in ICUs.
    Timsit JF; Soubirou JF; Voiriot G; Chemam S; Neuville M; Mourvillier B; Sonneville R; Mariotte E; Bouadma L; Wolff M
    BMC Infect Dis; 2014 Nov; 14():489. PubMed ID: 25431091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study.
    Teshome BF; Park T; Arackal J; Hampton N; Kollef MH; Micek ST
    Clin Infect Dis; 2024 Oct; 79(4):826-833. PubMed ID: 38842541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.